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AN ever-increasing number ofbiological systems have been shown to be affected
in the tumour-bearing host, but there have been few attempts to give a general
theory of the processes involved. The situation has perhaps been unnecessarily
complicated by the extensive use of animals bearing tumours weighing up to half
their body weight, which must make more difficult the recognition of the host
systems which are primarily affected. It seems reasonable to suppose that one
or two key effects of the tumour on the host begin at an early stage in its growth,
and rapidly snowball into the complex of lesions seen later.
As pointed out by Greenstein (1954), there are only two basic ways in which
a tumour is able to exert a general effect on its host. The tumour may either
abstract from the diet some component which is essential for the well-being of the
host, or it may elaborate some toxic agent and discharge it into the host circulation.
Taking the first alternative, the vast literature on the growth requirements of
tumours seems so far to have yielded little more than the negative result that
tumours require supplies of the protein components, carbohydrates, fats, and
accessory food factors, which are required for the growth of normal tissues.
There is evidence, however (Babson and Winnick, 1954), that tumours may utilise
serum proteins without prior hydrolysis into amino acids. This aspect has been
recently reviewed by LePage and Henderson (1960) but it does not seem likely
that any such difference between tumour tissue and normal tissue could explain
the effects of malignant tumours on their hosts.
One generally accepted property of tumours is their ability to grow and to
store nitrogen at the expense of the host. The " nitrogen trap " hypothesis
(Mider, Tesluk and Morton, 1948) was based on the suggestion that tumours take
up amino acids from, but do not contribute to, the general metabolic pool of the
host. Despite more recent evidence that there may in fact be an exchange between
tumour and host nitrogen (LePage and Greenlees, 1955; Finlayson, Forsberg
and Dreyfus, 1959) it still seems evident that the tumour-bearing host is at a
disadvantage compared with the tumour in the competition for dietary nitrogen.
White and Belkin (1945) found that tumours grew at 75 per cent of control
rate in mice maintained on a protein-free diet, and similar results have been
reported by other investigators. These results show that tumours can obtain
their requirements for growth from the body of the host, although obviously not in
full measure. There seems little evidence, however, that the ability oftumours to
growattheexpenseofthe host is greater than that ofrapidlygrowingnormaltissue.
Seegers (1937) showed that pregnant rats placed on a protein-free diet from the
11th day of gestation would produce viable young, although their weight at
birth was reduced. Liver will regenerate in starved animals (Williams, 1951;
Kennedy and Pearce, 1958), and also in tumour-bearing animals (Paschkis,
Cantarow, Stasney and Hobbs, 1955; Straube and Hill, 1956), and a foetus willD. H. ADAMS
grow well in pregnant tumour-bearing rats (Pashkis, Cantarow and Stasney, 1956;
Paschkis and Cantarow, 1958).
According to a recent review, iiicorporation studies lead to a similar conclusion,
showing that while tumour tissue combines a rapid uptake of amino acids with
a marked ability to concentrate them, these properties are shared by foetal
tissue, regenerating liver, and the tissues of young growing rats (LePage and
Henderson, 1960).
From the evidence so far cited it is difficult to see why the growth of a tumour
should have any greater effect on the host than pregnancy. Nevertheless one
inescapable fact is that wasting of the host to a greater or lesser extent is one of
the consequences of tumour growth. This may range from the failure of tumour-
bearing rats to gain weight as rapidly as controls (Begg, Dickinson and White,
1953) to the all-too familiar picture of severe cachexia in the tumour-bearing
patient or rodent. Sherman, Morton and Mider (1950) showed that those tissues
which relinquish their protein during starvation also yield up their nitrogen to
the tumour, witlh the exception of liver, spleen, and kidney, which retainnitrogen
in tumour-bearing but not in starved animals. The rate of glycine incorporation
into protein follows a similar pattern, glycine being more readily incorporated
into the liver and spleen of tumour-bearing mnice and less readily into muscle
than in control mice (Norberg and Greenberg, 1951). Thus simple inanition
resembles, but does not simulate exactly, the situation in the tumour-bearing
host.
There are in fact many reports in the literature that liver weight and nitrogen
content are increased in the tumour-bearing animal. It is, however, often
difficult to find out whether the liver weight/body weight ratio also increased,
and few investigators state clearly whether "body weight " includes the weight
of the tumour or not. Yeakel (1948) found that the livers of tumour-bearing
rats increased in weight, and Yeakel and Tobias (1951) that the liver nitrogen
content was proportional to the total mass of the animal. Bodansky and Scholler
(1956) found an increase in the liver weight/total weight ratio in their tumour-
bearing rats. Appleman, Skavinsky, and Stein (1950) found an increased liver
weight/total weight ratio intumour-bearing rats. but not in rats kept on a protein-
free diet. An increased protein content was observed in the livers of tumour-
bearing rats by Allison, Bernstein, and Babson (1954), and a rapid loss of livei
protein in animals kept on a protein-free diet. Similar results were obtained by
LePage, Potter, Busch, Heidelberger and Hurlbert (1952) in a comparison of
fasted rats with tumour bearers. Once again, however, a comparison with the
pregnant rat shows a similarity: the livers of such animals increase considerablv
in size, although approximately in proportion to the total weight (Poo, Lew and
Addis, 1939). These authors concluded that there was a 28 per cent increase
in the amount of protein allocated to the liver during pregnancv. Their figures
also show that the total weight ofpregnant rats increased from 150 to 231 g. in
18 days, compared with an increase to 172 g. in non-pregnant controls. Since
the foetal weight on the 18th day was 27 g. it would appear that the host carcass
gained weight at least as fast as the non-pregnant controls during this period of
rapid foetal growth, although the absence of figures giving the weight of the
uterine contents makes any precise assessment difficult. In experiments with
pregnant mice to check this point, reported in the present paper, an increase in
carcass weight was observed. It seems probable that the carcass of the pregnant
1540ACTION OF TUMOURS ON THEIR HOSTS
animal is capable of maintaining or gaining weight so long as the diet is adequate.
Ifthe diet is not adequate for the support of both mother and foetus then foetal
growth will continue at the expense of the maternal tissues. In this sense there-
fore there is a similarity between the tumour-bearing animal and the pregnant
animal on an inadequate diet.
Among the most striking and universal effects of malignant tumours in
rodenits is the associated fall in liver catalase activity. According to Greenstein
and Andervont (1943) liver catalase is unaltered during pregnancy, and this
reflects yet another difference between the growth of foetal and tumour tissue in
their effects on the host. Studies on the catalase-depressing action of tumours
have fallen into two main categories. Firstly the effects of starvation or protein
deficiency have been examined, usually in an attempt to simulate the catalase
changes in the tumour-bearing host. Appleman, Stavinsky and Stein (1950)
found that a protein-free diet depressed rat liver catalase activity to about the
same extent as did the growth of the Jensen rat sarcoma. The addition of
protein to the deficient diet caused a restoration of catalase activity to normal
within 1-3 days-a period similar to that found by Greenstein and Andervont
(1942) for the return to normal of the catalase activity of tumour-bearing rats
following surgical removal of the tumour. However, a high protein diet (Weil-
Malherbe and Schade, 1948) or force-feeding (Begg and Dickinson, 1951), did
not restore the catalase activity of tumour-bearing animals to normal. This
seems further evidence that the tumour-bearing host has been placed in a position
of inability to utilise sufficient dietary protein for its needs.
Secondly the effects of injecting tumour homogenates or fractions have been
studied. So far as liver catalase is concerned there is now considerable evidence
that the injection of these into normal animals results in changes resembling
those seen in tumour bearers. However, as recently pointed out (Adams, 1959,
1961), there is some doubt whether the action of such injections in depressing
catalase activity has relevance to the lowered catalase activity seen in the tumour-
bearing host.
It is quite possible that the tumour agent affects catalase activity indirectly,
by interfering with the utilisation of dietary protein by the host. There are
two ways in which this could be brought about. Firstly, the tumour agent may
alter the hormonal status of the host animal. Adams (1951, 1952) showed that
adrenalectomy in mice resulted in a decreased liver catalase activity (although
apparently not in rats (Begg, 1958)), and that both the testicular and adrenal
hormones which regulate catalase activity were antagonised in vivo by an agent
present in tumour homogenates. Recent work (Adams, 1959, 1960) has shown
that androgenic hormones and tumour homogenate injections altered the intra-
cellular distribution of liver catalase in opposite directions, and suggested that
androgens increase the permeability of large granule membranes to catalase while
an agent present in the tumour homogenates decreases it.
Considering adrenal secretion for the moment, an action of the tumour agent
in rendering some target tissues insensitive to the action of adrenal hormones
might thus affect liver catalase and moreover might well produce the adrenal
enlargement often noted in tumour-bearing animals. In his recent review Begg
(1958) suggested that " the large adrenal of the tumour-bearing animal is hyper-
functional and is producing considerable quantities of adrenal hormones".
Since Long and his co-workers showed that the administration of adrenal cortical
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extracts to animals resulted in an increased nitrogen excretion (e.g. Long, 1942),
a markedly increased adrenal secretion in the tumour-bearing animals would be
expected to increase tissue catabolism in the host. It is true that in the pregnant
rat there is also evidence of an increased adrenal cortical secretion, but this is
only between the 10th and 15th days of pregnancy and the figures suggest that
the highest secretion rate is only about two or three times the normal (Poulton
and Reece, 1957). It is significant that these authors found no increase in adrenal
weight at any stage of pregnancy. Thus adrenal hyperfunction appears to be
very much less in pregnant that in tumour-bearing animals.
Secondly the tumour agents may be a riboflavin antagonist or anti-metabolite.
It has been found that the liver of the tumour-bearing animal contains only
about two-thirds of its normal riboflavin (Masayama and Yokoyama, 1939;
Robertson and Kahler, 1942). This may be compared with the observation of
Vivanco (1935) that the livers of rats which had died of riboflavin deficiency still
contained about one-third of the normal riboflavin content. There is evidence of
a close association between riboflavin and nitrogen retention: Czackes and
Guggenheim (1946) found that on a low protein diet rats were unable to retain
or use riboflavin. Rats on a high protein diet required twice the normal quantity
of riboflavin. According to Kaunitz, Weisinger, Blodi, Johnson and Slanetz
(1954) riboflavin and protein are mutually limiting factors. Diets with a high
protein content cannot be utilised if their riboflavin content is restricted. Adams
(1955) found that the liver catalase activity of riboflavin deficient mice did not
respond to testosterone, and in the light of more recent work (Adams, 1960) this
suggests that riboflavin may also be a factor controlling intracellular catalase
distribution.
The present experiments were devised to contribute towards the solution of
the problem of how tumours produce their observed effects on the host. Body
and liver weights, liver total N, liver weight/body weight ratio, total, granule,
and EPC liver catalase activities, and intracellular catalase distribution, have
been measured in mice bearing Sarcoma 37, pregnant mice, and mice kept on diets
deficient in protein and/or riboflavin with or without treatment with cortisone.
MATERIALS AND METHODS
Animals.-Young adult mice of the 101 and CBA strains were used. These
animals were bred in this laboratory by brother-sister mating. The animals
were given water ad libitum.
Diets.-Three basic types of diet have been used.
(1) Commercial rat cubes (normal diet). Mice were fed this diet unless
otherwise stated.
(2) A protein and riboflavin-free diet of the composition:
Per cent
Starch (maize) 80
Sucrose . 10* 7
Agar 1.0
Arachis oil 5-0
Salt mix 2 0
(Hubbel Mendel and Wakeman, 1937)
Streptomycin . . . 025
Succinyl Sulphathiazole . . 025
Vitamin mix (no riboflavin) 08
(Adams, 1955)
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This diet was supplemented as required with riboflavin (5 ug./g.), and
with vitamin-free casein. In the latter case the quantity of starch was
reduced to maintain a constant composition of the other components.
(3) One of the problems associated with diets using vitamin-free casein
as the sole protein source is that there is a tendency for the animals to
reduce their overall food intake. This is probably due to the unpalatable
nature of the diet. In an effort to overcome this, particularly in those
experiments designed to study the effects ofriboflavin deficiency associated
with a reduced protein intake, the following diet was designed.
Ground lice . 80 per cent
Oatmeal 4
Sucrose 7 * 7
Arachis oil
Salt mix . . .
Streptomycin . S As in diet (2)
Sucernyl sulphathiazole
Vitamin mix (no riboflavii) J
This provides a palatable diet containing about 6 per cent of protein
and 0.1 ,ug./g. of riboflavin (low protein diet). Young adult mice placed
on this diet increased their body weight slowly when a riboflavin supple-
mnent (5 #g./g.) was added, and lost weight slowly in the absence of such a
supplement. However, both groups consumed similar amounts of diet.
In certain experiments vitamin-free casein (15 per cent) was added to
the diet with a corresponding reduction in the ground rice content.
Groups of young adult mice placed on this diet, with or without a ribo-
flavin supplement of 5 ,ug./g., did not reduce their food intake, and conse-
quently the observed differences between them were due to riboflavin
deficiency uncomplicated by a reduction in food intake.
Diets (2) and (3) were moistened with sufficient water to produce a
thick dough, which was cut up into small " biscuits " and dried at slightly
above room temperature. Riboflavin supplements were normally added
by dissolving the appropriate amount of riboflavin in the water before
addition to the powder.
Because the purpose of the work was to simulate the tumour-bearing
host, the experimental animals were allowed to eat their diets ad libitum.
Preparation of liver fractions and estimation of liver catalase activity.-Catalase
estimations were made on whole liver homogenates, and on granule and EPC
fractions and given in arbitrary units/mg. N of the whole homogenate. The
method of estimation of catalase activity has been fully described in previous
publications (Adams, 1950, 1952), and the preparation of the homogenates and
fractions by Adams and Burgess (1957, 1959a). Ethanol (final concentration
0-01 M.) was added to all catalase-containing solutions, to prevent loss of catalase
due to "Complex II " formation (Chance, 1950; Adams and Burgess, 1959b).
Liver nitrogen.-The figures quoted are for the total quantity of nitrogen per
liver, estimated by the Kjeldahl method.
Tumour.-Sarcoma 37 was obtained originally from the Imperial Cancer
Research Fund Laboratories, and maintained by serial passage in this laboratory.
Triton X 100.-This non-ionic detergent (kindly given to us by Charles Lennig
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& Co.) was used at a final concentration of 025 per cent v/v to disrupt large
granules and liberate their catalase activity into solution.
Cortisone.-" Cortisyl " (Roussel) (25 mg. cortisone/ml.) was injected intra-
peritoneally.
Riboflavin.-Where necessary this was injected intraperitoneally in the form
of " Beflavit " (Roche).
RESULTS
The tumour-bearing animal
Fig. 1 shows the effect of the growth of Sarcoma 37 on the liver catalase
activity and intracellular distribution, and on liver weight, liver total N, and body
weight of CBA female mice. By the end of the third week after the implantation
Time in weeks
FIG. 1. Effect of the growth of Sarcoma 37 on CBA female mice. Total liver catalase
A A, granule catalase 0 O, EPC catalase, * 0, catalase intracellular
distribution (G/EPC), liver weight * *, total liver nitrogen x x, host
weight (i.e. without the tumour) A A. The rate of tumour growth is given by
C0 01. In this and subsequent figures the results are given as arithmetic means
± standard error of means, with 6-8 animals per group. Catalase activities are expressed
in arbitrary units/mg. N, liver weight as total net weight, total liver N in mg. per whole
liver. Controls are at time 0.
of the tumour the animals were becoming moribund. Total and granule catalase
activities decreased progressively throughout the experiment, while the EPC
catalase decreased more rapidly than the granule catalase in the first two weeks,
and subsequently decreased more slowly. The granule/EPC catalase distribution
ratio increased to a maximum value of about 8 as previously reported, but
decreased again as the animals became moribund. Liver weight and total N
rose for the first two weeks, and then fell sharply. However, the changes in
liver N approximately paralleled the changes in wet weight i.e. there was little
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or no change in N concentration. Carcass weight fell after the first week and by
the terminal stages had decreased by 20-25 per cent. The ratio of the liver
weight/total weight increased to about 0 7 until the terminal stages when it
returned to normal.
The changes in liver weight/total weight ratio appear in Table I, and the
data obtained from all other experiments are also collected in this table.
TABLE I.-Liver Weight/Body Weight Ratios in Female Mice Subjected to Various
Treatments. In the Tumour-bearing and Pregnant Animals " Body Weight"
means Total Weight
Timie of treatment
(weeks)
Treatment 0 0 5 1 1 5 2 2 * 5 3 4 5 6 7
S37 growth (Fig. 1) 0 53 - 0 59 0-69 0-72 0 54 0-48 - -
Pregnancy (Fig. 2) 0.5 - 0 53 0*56 0 53
Protein-free diet + ribo- 0-51 0 49 0-5* 0 55 0 45 -
flavin (Fig. 3)
Protein-free diet, no ribo- 0 51 0 51 0-5* 0-54 - 0 54
flavin (Fig. 4)
Rice oatmeal (6%P) diet 0 55 - 0-58 0-58 0-56* 0 54 -
+ riboflavin (Fig. 5)
Rice oatmeal (6%P) diet, 0 55 - 0 58 0* 50 0.55* 0*56 -
no riboflavin (Fig. 6)
Riboflavin deficienev . 0-51 - 0- 53 - 0 51 0 49
(Fig. 7)
Rice oatmeal (6%P) diet 0 51 - - 0-83 - 0 65 - 0-58
+ riboflavin + corti-
sone (Fig. 8)
Ditto without riboflavin 0 51 0 78 - 0 65 0.5 - -
(Fig. 9)
* Protein supp1lement added to diet after this readinig.
The pregnant animal
The effect ofpregnancy on the various parameters is shown in Fig. 2. Because
of the uncertainty about the date of the beginning of pregnancy the graphs are
plotted against foetal weight instead of time. However, since the gestation
period of the mouse is about 3 weeks, the abscissae in Fig. 1 and 2 are approxi-
mately on the same time scale. In contrast to the tumour bearing animals,
granule catalase activity in the pregnant mice did not fall, and even rose slightly.
The EPC catalase activity fell significantly towards the end ofgestation, but never
reached the low level seen in the tumour bearers. However, the granule/EPC
catalase distribution ratio rose steadily in the pregnant animals to a value of 9.2,
which exceeds the value seen in the tumour bearers. There was an increase
in carcass weight, which approximately paralleled that seen in the non-pregnant
controls. Liver weight and total N rose considerably, but only in proportion to
the total weight of the mouse.
Effect ofprotein-free diets
The effect of maintaining 101 female mice on a protein- and riboflavin-free
diet (diet (2)) is shown in Fig. 3, and on a protein-free diet supplemented with
riboflavin in Fig. 4. After 10 days, the catalase activities had fallen, and the
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FIG. 2. Effect of pregnancy on total liver catalase A A, granule catalase 0 0,
EPC catalase * *, catalase distribution (G/EPC), liver weight *- *, total
liver N x x, carcass weight (i.e. without foetuses, placentas and uteri) A A.
CBA female mice.
4
Time in weeks
FIG. 3.-Effect of a protein-free diet supplemented with riboflavin on total liver catalase
A A, granule catalase 0 O, EPC catalase * 0, catalase distribution
(G/EPC), liver weight * *, total liver N x x, and bodyweight A A ^.
At the points marked t, 15 per cent of vitamin-free casein was added to the diet. 101
female mice.
i
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intracellular distribution had risen, in both groups to about the values found in
the tumour bearers. However, in contrast to the tumour bearers, there was no
increase in liver weight or total N and the liver weight/body weight ratio remained
unchanged. Body weight was lost very rapidly, more rapidly in fact than from
the carcass of the tumour bearers. After the 10th day vitamin-free casein
(15 per cent final concentration) was added to the diet. In both groups this was
followed within 4 days by a return of catalase activity to normal, and an increase
in liver weight and total N and in body weight. In the riboflavin deficient group,
however, the increase in body weight and liver N was not maintained.
FIG. 4.-As Fig. 3 but without anv addition of riboflavin to the diet.
Low protein, low riboflavin diets
Further experiments were carried out using the 6 per cent protein rice-oatmeal
diet (diet (3)). As Fig. 5 shows, mice placed on this diet plus a riboflavin supple-
ment maintained or increased their liver and body weights, and there was a
slight fall in liver total N. There was little or no change in granule catalase
activity, but the EPC catalase activity fell sharply and the average granule/EPC
ratio was about 10 from the first to the third week. In the group receiving no
riboflavin supplement (Fig. 6) liver weight and total N and body weight all fell
slowly. The granule catalase activity decreased, as well as the EPC catalase
activity, giving an increase in distribution ratio to about 8. In both groups
there was no change in the liver weight/body weight ratio. When the diets of
both groups were supplemented with vitamin-free casein (15 per cent) after
3 weeks, catalase activities and distribution ratios rapidly returned towards
normal.D. H. ADAMS
Time in weeks
FIG. 5.-Effect of a rice-oatmeal diet containing 6 per cent of protein on total liver catalase
A -A, granule catalase 0 O, EPC catalase 0 0, liver weight
* -- , total liver N x x, and body weight A A. CBA female mice.
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FIG. 6.-As Fig. 5, but without any addition of riboflavin to the diet.
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Riboflavin deficiency alone
Fig. 7 shows the effect of riboflavin deficiency alone. In this experiment two
groups of mice were fed on diet (3) supplemented with 15 per cent casein, and in
the case of one group, with riboflavin. There was no change in the EPC catalase
level in either group. but the granule catalase activity fell in the riboflavin-
deficient group, with a consequent decrease in the granule/EPC distribution ratio
to about 4-4.
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FIG. 7.-Effect of riboflavin deficiency on CBA female mice. The mice were fed on a rice-
oatmeal (6 per cent protein) diet supplemented with 15 per cent of vitamin-free casein,
supplemented with riboflavin (points joined by continuous lines) and without a riboflavin
supplement (points joined by dotted lines). Total catalase A, granule catalase Q, EPC
catalase *, catalase distribution (G/EPC) liver weight U, total liver N x, body weight A.
Cortisone injections in association with a low protein diet
In further experiments mice were placed on diet (3), half being given a ribo-
flavin supplement, the others not. After 1 week each group was divided into two>
and one half of each group injected with 15 mg. of cortisone/day. The results.
appear in Fig. 8 (riboflavin supplemented) and Fig. 9 (riboflavin deficient). They
show that the cortisone injections accelerated the fall in total catalase activity,
particularly in the riboflavin-deficient group, and restored the granule/EPC
distribution ratio to normal in the case of the riboflavin-supplemented group,
and to that characteristic of riboflavin deficiency without protein deficiency in
the riboflavin-deficient group. Associated with the marked fall in catalase
activity was a fall in body weight and an initial rise in liver weight and liver N.
The liver weight/body weight ratio was increased to about the value found ini
tumour bearing animals. After 2-3 weeks ofcontinuous treatment the riboflavin-
deficient animals began to die.
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FIG. 8.-Effect of the daily injection of cortisone (1-5 mg./day) on CBA female mice main-
tained on a rice-oatmeal (E per cent protein) diet supplemented with riboflavin. Mice were
placed on the dieT at time 0. After 1 week ( t ) they were divided into two groups, one
being given cortisone (points joined bv continuous lines) and one not (points joined by
dotted lines). Total catalase A, granule catalase, 0, EPC catalase 0, liver weight C,
total liver N x, body weight A.
FIG. 9.-As Fig. 8, but without any addition of riboflavin to the diet.
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In a separate experiment mice were placed on diet (3) with and without
riboflavin for two weeks, and then injected with 1*5 mg. cortisone/day for ten
days. The diet of both groups was then supplemented with 15 per cent casein,
and the cortisone injections were continued. In the group receiving riboflavin
there was a rapid response to the protein supplement, catalase activity and body
weight returning approximately to normal after a few days. Of the nine ribo-
flavin-deficient mice remaining at this point, five showed no reaction at all to the
protein supplement, and in fact continued to lose weight. The catalase activity
and body weight of the other four mice did rise but not to the extent of those
receiving riboflavin (Fig. 10).
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FIG. 10.-Effect of the supplementation with vitarin-free casein (15 per cent final concentra-
tion) ofmice maintained on a rice-oatmeal (6 per cent protein) diet for 3 weeks, and injected
after Iweek with 1-5 mg. cortisone/day. Half the mice received a riboflavin supplement,
the other half not. Time 0 represents the situation after 3 weeks on the diet, and the
protein supplement was added at this point. Graphs (a) (c) (e) no riboflavin, graphs (b) (d)
(f) with riboflavin. In graphs (a) (c) and (e) half the animals responded to the protein
supplement and half not (see text). Each group is therefore represented separately.
Pregnant mice treated with cortisone
Table II shows that the raised catalase granule/EPC distribution ratio resulting
from pregnancy was restored approximately to normal in mice treated with 1 mg.
of cortisone/day for 4 days.
Effect of cortisone injection or riboflavin supplementation in the tumour-bearing
animal
A number of male CBA mice were divided into 3 groups. Two groups were
maintained on a normal cube diet, and the third group on a diet ofcubes moistened
with a riboflavin solution and subsequently dried, giving an extra 200 ,ug./day of
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TABLE II.-Effect of the Injection of 1 my. Cortisone/day for 4 days on Catalase
Activity and Distribution of Pregnant CBA Mice. Catalase Activities are
given in Arbitrary Units/mg. N Arithmetic Means ± Standard Error ofMeans.
Six Pregnant Mice per Group and 8 Non-pregnant Controls not Injected with
Cortisone
Mean foet-al
weight Granule EPC
(g.) catalase catalase G/EPC
Pregnant mice injected with cortisone 4-8 410+11 70+3- 2 5- 8
Pregnant mice not injected with cor- 4-5 500±15 74±3-5 7-4
tisone
Non-pregnant controLs . 435±7- 84±2-0 . 5-2
riboflavin. After one week all these groups were inoculated with Sarcoma 37.
The group receiving the riboflavin-supplemented diet was also given a further
200 ,tg./day of riboflavin by injection. One of the two remaining groups was
injected with 1-5 mg. of cortisone daily.
In the cortisone-treated group the rate of S37 growth was reduced, but the
animals began to die when the tumour weightreached about one gram. As shown
inFig. 11 and 12 no difference in total catalase activity orgranule/EPCdistribution
ratio was seen comparing the untreated and cortisone treated tumour bearers.
It is also evident that supplementing the diet of tumour bearers with riboflavin
had little effect.
Dietary intake
The dietary intake of mice kept on the various regimes was measured and the
results are summarised in Table III. It seems clear from these results that the
various regimes did not produce their effects by causing the animals to restrict
their food intake.
TABLE III.-Dietary Intake of Mice Maintained on the Various Regimes. The
Food Intake was Measured Daily (in grams) and Averaged over Weekly Periods
Weaks
RegiIne 1 2 3 4 5 6 7
Cubes . . . . . 43 4-0 4 3 5-1 5-2 5-5 -
Protein-free diet + riboflavin . . 4-0 *5-8 5-2 - -
Protein-free diet, no riboflavin . 3 3 *5-8 3-7
Rice-oatmealdiet(6%P) + riboflavin. 4-5 4-6 4-1 *5-0 5-2
t4-6
Rice-oatmeal diet, no riboflavin . . 4-9 4-3 4-6 *4-8 4-5
t4-8
Pregnant, fed cubes . . . 5-5 6-0 - -
Tumour bearers, fed cubes . . . 4-0 5-2 6-5 - -
Riboflavin-deficient . . . . 4-0 2-8 3-1 3-0 2-9 3-1 3-2
Controls for above (with riboflavin) . 3-2 2-3 3-9 3-1 3-1 3-1 3-3
* Casein added to diet at end of previous week.
t Cortisone (1-5 mg./day) injected at end of previous week.
DISCUSSION
The changes in the various parameters measured, using the various diets, are
summarised in Table IV. The results obtained using cortisone are not included
in the table.
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The results show that pregnancy does affect liver catalase activity in mice,
in contrast to the report ofGreenstein and Andervont (1943) that catalase activity
remained normal in pregnant rats. However, the effects were much less severe
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than with tumour-bearing animals. The pregnant mice also supported the growth
of 6 g. of foetal tissue plus about 2 g. of placental and uterine tissue over a period
of 18 days without loss of carcass weight. In contrast the tumour bearers lost
20-25 per cent of their body weight while supporting the growth of about 4 g. of
tumour tissue over the same period. The liver weight and total N increased in
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both pregnant and tumour-bearing mice. However, the liver weight/total weight
ratio increased only in the tumour bearers. In the late stages of tumour growth
the ratio returned to normal, and the liver weight and total N fell sharply, but
in the pregnant mice the increased liver weight and N were maintained
throughout.
The results obtained using the various diets suggest that an increased granule/
EPC catalase distribution ratio is a reflection of a mild protein deficiency in
the host. However, there seems to be no parallelism between the severity of the
protein deficiency and the catalase distribution ratio. In animals maintained
on a protein-free diet, the catalase distribution ratio rose rapidly to a value of
about 7-5, and the absence of a riboflavin supplement made no detectable differ-
ence. However, in the animals kept on the rice-oatmeal diet (diet (3), containing
about 6 per cent protein), the catalase distribution ratio reached about 8 when
there was no riboflavin supplement, and about 10 when a riboflavin supplement
was included in the diet. This difference in distribution ratio occurred largely
becausethere was little or no fall in granule catalase activityin the group receiving
riboflavin. In fact a comparison of the results obtained with the various groups
of animals shows that in the pattern of the changes in catalase level there were
marked similarities between the pregnant mice and the normal mice kept on
diet (3) supplemented with riboflavin, and between the tumour-bearing mice and
the mice kept on diet (3) unsupplemented with riboflavin. The difference between
the pregnant and tumour-bearing mice may therefore be partly explained on the
supposition that an agent secreted by the tumours has the properties of a ribo-
flavin antagonist or antimetabolite. However, the mice kept on diet (3) in the
absence of riboflavin did not simulate quantitatively the tumour-bearing hosts.
Firstly their catalase activities did not reach the low levels seen in the tumour-
bearing host, and secondly there was no increase in liver weight, or liver weight/
body weight ratio.
The mice kept on the protein-free diet (diet 2) also failed to simulate the
tumour-bearing hosts quantitatively. Although the catalase activity in both
intracellular fractions rapidly reached the low levels seen in tumour-bearing
animals, this was achieved at the expense of a more rapid loss in carcass weight,
and an associated rapid loss in liver weight and total N. Also there was no
increase in the liver weight/body weight ratio.
The results also show that when animals kept on either diet (2) or (3) were sub-
sequently fed protein, their catalase activity and distribution ratio were rapidly
restored to values not far from normal. As mentioned in the introduction Begg
and Dickenson (1951) found that force feeding additional protein to tumour-
bearing animals did not restore their catalase activity. It is true that those
mice kept on diets (2) or (3) with no riboflavin supplement failed to gain body
weight when protein was subsequently fed, but this did not prevent a rapid rise
in catalase activity. This result agrees with that obtained by feeding a diet
containing 20 per cent protein (diet (3) supplemented with 15 per cent ofvitamin-
free casein) with or without riboflavin. After 7 weeks on the diet the body weight
of the riboflavin-deficient group had fallen, and that of the group receiving
riboflavin had risen. The only change in catalase levels was a slight fall in the
granule activity of the riboflavin-deficient group, with a consequent fall in the
granule/EPC ratio to about 4-3. It is perhaps of interest that, as with the mice
kept on diet (3) in the presence and absence of riboflavin, a riboflavin supplement
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appeared to have the effect ofmaintaining granule catalase activity, and increasing
the granule/EPC distribution ratio compared with the riboflavin-deficient group.
When animals maintained on diet (3) with or without riboflavin were injected
with cortisone in sufficient amounts to cause a marked tissue catabolism certain
striking changes were seen. Firstly, within a period of 4 days the increased
catalase granule/EPC distribution ratio was restored to normal in those animals
receiving a riboflavin supplement, and to that characteristic of riboflavin defi-
ciency in those animals not receiving riboflavin. This suggests very strongly that
cortisone acts on the permeability of the granules to catalase in the same way
as androgenic hormones (Adams, 1960). Table II shows that the increased
catalase distribution ratio in pregnant mice was also restored to approximately
normal when these animals were given cortisone. In contrast, the increased
granule/EPC distribution ratio in tumour bearers did not alter even with the
massive amounts of cortisone injected, showing that this action of cortisone is
blocked in the tumour-bearing animal.
However, the remaining changes in the cortisone-treated animals, particularly
in the riboflavin-deficient group, were strikingly similar to those seen in the
tumour bearers. There was an initial increase in liver weight and total N, but
both subsequently fell below normal. The rate of loss of body weight was
increased to about that seen in tumour bearers, the liver weight/body weight
ratio was increased to about the same extent, and total catalase activity fell to
the low levels found in tumour bearers. If in fact the action of cortisone on the
catalase distribution ratio had been blocked in these cortisone-treated animals
they would have simulated the tumour bearers closely in every respect studied.
The changes in the group receiving a riboflavin supplement were not so pronounced
and the catalase distribution ratio before cortisone was injected exceeded that of
tumour bearers. The results also show that when the diets were supplemented
with 15 per cent casein, there was an immediate recovery in this group. In the
riboflavin-deficient group on the other hand over half the animals showed no
response at all to the protein supplement, and the reaction of the remainder was
much less than that of the riboflavin-supplemented animals.
Although the results suggest that the tumour-bearing host is in a state of
riboflavin deficiency there is other evidence that this may be a simulated rather
than an actual state. Evidence against riboflavin deficiency is provided by the
normal level of the activity ofriboflavin containing enzyme liver xanthine oxidase
in the tumour-bearing animal (Greenstein, Jenrette, Mider and White, 1941;
Greenstein, Jenrette and White, 1941; Begg, 1955; Burton, 1956). However,
this might be explained by the fact that the effect of a riboflavin antagonist or
antimetabolite secreted by the tumour, could differ in some respects from that
of riboflavin deficiency. The high riboflavin diet coupled with injections of
riboflavin had little effect on the catalase activity of the tumour-bearing host.
However, there was an indication that the riboflavin-supplemented host lost
weight less rapidly. Because the effect was slight, the results were not given
previously. In six male mice bearing tumours averaging 2-5 g. the host weight
was 19-8 ± 03 g. and in a similar group ofriboflavin-treated mice the host weight
was 21-2 ± 0-5 g.
In connection with the possibility that the tumour-bearing animal shows
only a simulated riboflavin deficiency, it is of interest that Burch, Hunter, Combs
and Schutz (1960) found a reduced capacity for oxidative phosphrylation in
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mitochondria prepared from the livers of riboflavin-deficient rats. It seems
probable that this is at least one factor in the lowered utilisation ofprotein caused
by riboflavin deficiency (Sure and Dichek, 1941 ; Sure, 1941). Possibly therefore
the tumour agent is an inhibitor of oxidative phosphorylation rather than a direct
riboflavin antagonist. This point will be investigated in further studies.
The present experiments show a fall in total catalase with protein deprivation
or depletion, but in neither case was there any increase in the liver weight/body
weight ratio. The diet containing 6 per cent of protein together with cortisone
injections resulted in decreases in total catalase activity as great as those seen in
mice fed on protein-free diet, and this regime also resulted in an increase in the
liver weight/body weight ratio. The animals fed on 6 per cent protein diet and
injected with cortisone failed, however, to simulate the tumour bearers in two
respects. Firstly, they lost body weight more slowly, and secondly, their catalase
granule/EPC distribution ratios were too high. The imposition of a state of
riboflavin deficiency in addition to the low protein-cortisone regime increased
their rate of loss of body weight and reduced the granule/EPC distribution ratio
to that found in tumour bearers. Further, it was found that injection of cortisone
into tumour bearers did not further depress their total catalase.
It is suggested therefore that the situation in the tumour-bearing host may
be explained in the following way. Firstly, the animals behave as though they
were being maintained on a low protein diet, and in this respect simulate the
pregnant animal. However, the pregnant animal was able, in the present studies,
to support the growth of additional tissue at twice the rate of tumour growth,
and to maintain or increase its carcass weight. The situation in the pregnant
animal seems therefore to be one of protein "' stress " produced by simple
competition between maternal and foetal tissue for dietary nitrogen. In the
tumour bearer thero appears to be a similar competition, but in addition a secre-
tion by the tumour of an agent or agents which
(a) Block the action of adrenal hormones on the permeability of
intracellular granules, and possibly on other organs.
(b) Induce a hypersecretion of adrenal steroids to many times the
normal rate, possibly as a result of (a).
(c) Act to cause or simulate a riboflavin deficiency.
Thus the action of tumour homogenate injections in increasing the catalase
granule/EPC distribution ratio in female mice would be due. as previously
supposed (Adams, 1951, 1959), to the blocking ofthe effects ofcortisone on granule
permeability by an agent present in the tumour. The rise in this ratio in the
tumour-bearing host could similarly be explained by the effect of tumour agents
on the action of endogenous adrenal steroids. With regard to the fall in catalase
activity, it is not necessary to assume that tumour agents directly depress total
catalase activity in the tumour-bearing host. The fall could be due to mecha-
nisms (b) and/or (c) and be secondary to impairment of N retention. It is also of
interest that although androgens injected in sufficiently high doses caused imme-
diate depressions in catalase activity superimposed on the alteration in intra-
cellular distribution (Adams, 1960), cortisone in similar doses (Fig. 9) may effect
the catalase distribution ratio before depressing catalase activity to any extent.
The results suggest that the lowered catalase activity produced by cortisone
injection is due to the induced tissue catabolism.
557D. H. ADAMS
There are other general points arising from the hypothesis. Firstly, it would
seem to provide an explanation of the " nitrogen trap "-not by suggesting that
tumours have any unique power ofnitrogen uptake, but that the tumour secretes
agents which interfere with the ability ofhost tissues to retain nitrogen. Secondly,
it enables an explanation to be provided of the wide variations in the effects of
tumours on, for example, the body weight ofthe host. In the extremes a rapidly
growing tumour producing large quantities of agents might be expected to have
the most severe effects on the host, while a slow growing tumour producing small
quantities of agents might affect its host only slightly.
Thirdly, the results have shown that cortisone-treated mice maintained on a
low protein- and riboflavin-deficient diet begin to die in an emaciated state
within 3 weeks, and the cause of death presumably is an inability to maintain the
levels of essential proteins. As already pointed out, this time of 3 weeks is about
that in which a subcutaneously implanted Sarcoma 37 begins to kill its host.
Clearly, however, the dietary regime could not simulate death due to metastatic
involvement of vital organs, and death from such a cause may often precede
what Begg (1958) has called the " metabolic death " of the host.
At present virtually nothing is known about the significance of these tumour
agents, but it seems possible that the suggested actions ofthe secreted agents may
assist tumour growth. If the host is largely unable to utilise dietary nitrogen
this presumably means that competition for the available material is weighted
in favour ofthe tumour. In this connection there seems no difficulty in explaining
why the tumour is not itself affected by, for example, an increased cortisone
secretion. Roberts (1953) showed that tissue proteins labilised by pituitary-
adrenal cortical stimulation may be utilised for liver regeneration. He suggested
that the primary effect of adrenal cortical secretion involves an accelerated
mobilisation of protein in the form of plasma proteins, and that the end result
locally may be anabolism or catabolism depending on the tissue requirement
for protein at the time. It seems possible therefore that the induction of an
adrenal hypersection by the tumour may be a method of rapidly providing the
building blocks for tumour growth.
One important question is, what would be the effect on the tumour and on the
host of preventing the action of the secreted agents. At present this cannot be
done completely, because of our ignorance of the primary cause of the simulated
riboflavin deficiency in the host. However, a combination of such procedures as
adrenalectomy with maintenance therapy, a high protein and high riboflavin diet,
and treatment with an anabolic androgen might be worth considering. It does
not seem unreasonable to hope that some retardation of the rate of tumour
growth coupled with prolongation of the life of the host and protection from
wasting might be achieved by proceeding along these lines.
SUMMARY
(1) The effect of the growth of Sarcoma 37 on the total catalase activity,
body weight, liver weight and total nitrogen of host mice is closely simulated by
maintaining normal mice on a diet containing 6 per cent of protein and deficient
in riboflavin, and injecting them daily with 15 mg. of cortisone.
(2) When cortisone is injected into tumour-bearing mice, protein deficient
mice or pregnant mice, all of which have a raised catalase granule/EPC distri-
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bution ratio, the ratio is restored to normal in all but the tumour-bearing group.
(3) It is suggested that tumours release into circulation agents which have the
properties of a riboflavin antagonist or antimetabolite, block the effect of adrenal
hormones on some target tissues, and induce a marked adrenal hyperfunction.
As a result the tumour-bearing host is largely unable to utilise dietary nitrogen.
The expenses of this research were partly defrayed out of a block grant from
the British Empire Cancer Campaign. My thanks are due to Dr. M. H. Salaman
for his interest, and to Miss I. M. Harris for skilled technical assistance.
Postscript
After this manuscript was completed, a paper by Hilf, Burnett and Borman
(1960) reached me, which on the basis ofthymus and adrenal weights and adrenal
and plasma corticosterone levels in mice, suggested that a growing tumour
(Sarcoma 180) induces an adrenal response resembling that resulting from a
non-specific chronic stress situation.
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